Fig. 7From: Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancerSchematic representation of the role and regulation of INMT in CRPC. The underlying mechanisms by which INMT promotes lethal prostate cancer development (left panel), and the therapeutic strategies based on targeting INMT or SMYD3 or/and the combination of INMT or SMYD3 inhibition with INMT methylation substrates (right panel)Back to article page